CARDIAC ONCOLOGY: A MODERN VIEW ON THE PROBLEM OF CHOOSING AN OPTIMAL STRATEGY FOR THE TREATMENT OF CORONARY ARTERY DISEASE AND CANCER
Bagrat G. Alekyan,
Narek G. Karapetyan,
Aleksandr A. Gritskevich,
Lilit G. Gyoletsyan,
Arthur V. Galstyan,
Amiran Sh. Revishvili https://doi.org/10.17802/2306-1278-2023-12-3-98-108
Abstract
Highlights
The article presents an overview of the main studies on the treatment of patients with coronary artery disease and cancer.
Abstract
Cardiovascular and oncological diseases remain the leading causes of death globally. The combination of coronary artery disease and cancer is becoming more common in clinical practice. Despite the achievements in the treatment of both of these diseases separately, their combination is a considerable issue for specialists. This review article discusses the main issues of managing patients with cancer and coronary artery disease. Moreover, the article presents various treatment strategies, including simultaneous and step-by-step interventions, and shows the current trends of endovascular approach to the treatment of these patients.
About the Authors
Bagrat G. Alekyan
Federal State Budgetary Institution “National Medical Research Center of Surgery named after A. Vishnevsky” of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
PhD, Professor, Academician of Russian Academy of Sciences, Head of Endovascular Surgery Center, Federal State Budgetary Institution “National Medical Research Center of Surgery named after A. Vishnevsky” of the Ministry of Health of the Russian Federation, Moscow, Russian Federation
Narek G. Karapetyan
Federal State Budgetary Institution “National Medical Research Center of Surgery named after A. Vishnevsky” of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
PhD, Senior Researcher, Associate Professor, Endovascular Surgeon at the Endovascular Surgery Center, Federal State Budgetary Institution “National Medical Research Center of Surgery named after A. Vishnevsky” of the Ministry of Health of the Russian Federation, Moscow, Russian Federation
Aleksandr A. Gritskevich
Federal State Budgetary Institution “National Medical Research Center of Surgery named after A. Vishnevsky” of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
PhD, Head of the Urology Department, Federal State Budgetary Institution “National Medical Research Center of Surgery named after A. Vishnevsky” of the Ministry of Health of the Russian Federation, Moscow, Russian Federation
Lilit G. Gyoletsyan
Federal State Budgetary Institution “National Medical Research Center of Surgery named after A. Vishnevsky” of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
PhD, Cardiologist at the Endovascular Surgery Center, Federal State Budgetary Institution “National Medical Research Center of Surgery named after A. Vishnevsky” of the Ministry of Health of the Russian Federation, Moscow, Russian Federation
Arthur V. Galstyan
Federal State Budgetary Institution “National Medical Research Center of Surgery named after A. Vishnevsky” of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Postgraduate Student, Endovascular Surgery Center, Federal State Budgetary Institution “National Medical Research Center of Surgery named after A. Vishnevsky” of the Ministry of Health of the Russian Federation, Moscow, Russian Federation
Amiran Sh. Revishvili
Federal State Budgetary Institution “National Medical Research Center of Surgery named after A. Vishnevsky” of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
PhD, Professor, Academician of Russian Academy of Sciences, Director of Federal State Budgetary Institution “National Medical Research Center of Surgery named after A. Vishnevsky” of the Ministry of Health of the Russian Federation, Moscow, Russian Federation
References
1. Pearse R.M., Clavien P.A., Demartines N., Fleisher L.A., Grocott M., Haddow J., et al. Global patient outcomes after elective surgery: Prospective cohort study in 27 low-, middle- and high-income countries. British Journal of Anaesthesia. 2016; 117. doi:10.1093/bja/aew316.
2. World health statistics 2021: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2021.
3. Al-Kindi S.G., Oliveira G.H. Prevalence of Preexisting Cardiovascular Disease in Patients with Different Types of Cancer the Unmet Need for Onco-Cardiology. Mayo Clinic Proceedings. 2016; 91:81–3. doi:10.1016/j.mayocp.2015.09.009.
4. Koene R.J., Prizment A.E., Blaes A., Konety S.H. Shared risk factors in cardiovascular disease and cancer. Circulation. 2016; 133:1104–14. doi:10.1161/CIRCULATIONAHA.115.020406.
5. Navi B.B., Reiner A.S., Kamel H., Iadecola C., Okin P.M., Elkind M.S.V., et al. Risk of Arterial Thromboembolism in Patients With Cancer. J Am Coll Cardiol. 2017;70. doi:10.1016/j.jacc.2017.06.047.
6. Zamorano J.L., Lancellotti P., Muñoz D.R., Aboyans V., Asteggiano R., Galderisi M., et al. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines: The task force for cancer treatments and cardiovascular toxicity of the european society of cardiology (ESC). Russian Journal of Cardiology 2017;143. doi:10.15829/1560-4071-2017-3-105-139.
7. Das D., Asher A., Ghosh A.K. Cancer and Coronary Artery Disease: Common Associations, Diagnosis and Management Challenges. Current Treatment Options in Oncology 2019;20:46. doi:10.1007/s11864-019-0644-3.
8. Lyon A.Rr, López-Fernández T., Couch L.S., Asteggiano R., Aznar M.C., Bergler-Klein J., et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). European heart journal. 2022;43:4229–361. doi:10.1093/eurheartj/ehac244.
9. da Silva R.M.F.L. Effects of Radiotherapy in Coronary Artery Disease. Current Atherosclerosis Reports. 2019;21. doi:10.1007/s11883-019-0810-x.
10. Sardar P., Kundu A., Chatterjee S., Nohria A., Nairooz R., Bangalore S., et al. Long-term cardiovascular mortality after radiotherapy for breast cancer: A systematic review and meta-analysis. Clinical Cardiology. 2017;40. doi:10.1002/clc.22631.
11. Trashkov A.P., Vasiliev A.G., Tsygan N.V., Khaitsev N.V., Marchenko S.P., Naumov A.B., et al. Antithrombotic therapy in oncology: contemporary concepts and pending problems. Pediatrics, 2012;3. (In Russian)
12. Johnstone C., Rich S.E. Bleeding in cancer patients and its treatment: a review. Annals of Palliative Medicine 2018;7:265–73. doi:10.21037/apm.2017.11.01.
13. Devereaux P.J., Goldman L., Cook D.J., Gilbert K., Leslie K., Guyatt G.H. Perioperative cardiac events in patients undergoing noncardiac surgery: A review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ. 2005;173. doi:10.1503/cmaj.050011.
14. Botto F., Alonso-Coello P., Chan M.T.V., Villar J.C., Xavier D., Srinathan S.K., et al. Myocardial Injury after Noncardiac Surgery: A Large, International, Prospective Cohort Study Establishing Diagnostic Criteria, Characteristics, Predictors, and 30-day Outcomes. Anesthesiology. 2014;120. doi:10.1097/ALN.0000000000000113.
15. Devereaux P.J., Szczeklik W. Myocardial injury after non-cardiac surgery: diagnosis and management. European Heart Journal 2020;41:3083–91. doi:10.1093/eurheartj/ehz301.
16. Devereaux P.J., Biccard B.M., Sigamani A., Xavier D., Chan M.T. v., Srinathan S.K, et al. Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery. JAMA. 2017;317:1642. doi:10.1001/jama.2017.4360.
17. Mol K.H.J.M., Hoeks S.E, Liem V.G.B., Stolker R.J, van Lier F. Postoperative troponin release is associated with major adverse cardiovascular events in the first year after noncardiac surgery. International Journal of Cardiology. 2019;280. doi:10.1016/j.ijcard.2019.01.035.
18. Halvorsen S., Mehilli J., Cassese S., Hall T.S., Abdelhamid M., Barbato E., et al. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. EuropeanHeart Journal. 2022. doi:10.1093/eurheartj/ehac270.
19. Dalton M.L., Parker T.M., Mistrot J.J., Bricker D.L. Concomitant coronary artery bypass and major noncardiac surgery. Journal of Thoracic and Cardiovascular Surgery 1978;75. doi:10.1016/s0022-5223(19)41251-8.
20. Miller D.L., Orszulak T.A., Pairolero P.C., Trastek V.F., Schaff H.V. Combined operation for lung cancer and cardiac disease. The Annals of Thoracic Surgery. 1994;58. doi:10.1016/0003-4975(94)90442-1.
21. Danton M.H.D, Anikin V.A., McManus K.G., McGuigan J.A., Campalani G. Simultaneous cardiac surgery with pulmonary resection: Presentation of series and review of literature. European Journal of Cardio-Thoracic Surgery. 1998;13. doi:10.1016/S1010-7940(98)00088-8.
22. Ma X. Huang F., Zhang Z., Song F., Ou S. Lung cancer resection with concurrent off-pump coronary artery bypasses: safety and efficiency //Journal of thoracic disease. 8.8 (2016): 2038. https://doi: 10.21037/jtd.2016.07.67.
23. Guha A., Dey A.K., Kalra A., Gumina R., Lustberg M., Lavie C.J., et al. Coronary Artery Bypass Grafting in Cancer Patients: Prevalence and Outcomes in the United States. Mayo Clinic Proceedings. 2020;95:1865–76. doi:10.1016/j.mayocp.2020.05.044.
24. Davydov M.I., Akchurin R.S., Gerasimov S.S., Dzemeshkevich S.L., Brand Ia.B., Dolgov I.M., Shestopalova I.M. Simultaneous surgery of competing cardio-vascular and malignant diseases of lungs and mediastinum. Pirogov Russian Journal of Surgery. 2010:4–10. (In Russian)
25. Porkhanov V.A., Barbukhatti K.O., Kononenko V.B., Belash S.Yu., Kovalenko A.L., Skopets A.A., Sitnik S.D., Polyakov I.S. Simultaneous operations on the heart and lung in CHD and malignant lung pathology in conditions of artificial blood circulation. Clinical and Experimental Surgery. Petrovsky Journal. 2013; (1). 17–23. (In Russian)
26. Porkhanov V.A., Barbukhatti K.O., Kononenko V.B., Belash S.A., Kovalenko A.L., Skopets A.A. et. al. Simultaneous surgeries for co-existing lung cancer and coronary artery disease. Grudnaya i serdechno-sosudistaya khirurgiya. 2016; 58:114–21. (In Russian)
27. Gerasimov S.S., Davydov M.I., Davydov M.M. Up-to-date strategy for surgical treatment of cancer patients with severe concomitant cardiovascular diseases. Rossiiskii onkologicheskii zhurnal. (Russian Journal of Oncology). 2019; 23 (3–6): 120–128. doi: http://dx.doi.org/10.18821/1028-9984-2018-23-3-6-120-128. (In Russian)
28. Alekyan B.G., Grigor'yan A.M., Staferov A.V., Karapetyan N.G. Endovascular diagnostics and treatment in the Russian Federation (2021).Russian Journal of Endovascular Surgery. 2022; 9 (Special Issue): 5-254. doi: 10.24183/2409-4080-2022-9S-S5-S254. (In Russian)
29. Ciriaco P., Carretta A., Calori G., Mazzone P., Zannini P.. Lung resection for cancer in patients with coronary arterial disease: Analysis of short-term results. European Journal of Cardio-thoracic Surgery, vol. 22, 2002. doi:10.1016/S1010-7940(02)00209-9.
30. Voltolini L., Rapicetta C., Luzzi L., Paladini P., Ghiribelli C., Scolletta S., et al. Lung resection for non-small cell lung cancer after prophylactic coronary angioplasty and stenting: Short- and long-term results. Minerva Chirurgica. 2012;67.
31. Potts J.E., Iliescu C.A., Lopez Mattei J.C., Martinez S.C., Holmvang L., Ludman P., et al. Percutaneous coronary intervention in cancer patients: A report of the prevalence and outcomes in the United States. European Heart Journal. 2019;40. doi:10.1093/eurheartj/ehy769.
32. Nikitina T.G., Dombrovskiy M.M., Alekyan B.G., Davydov M.I., Bockeria L.A. Coronary artery stenting in patients with coronary heart disease and cancer. Creative Cardiology. 2016; 10: 296–305. doi:10.15275/kreatkard.2016.04.04. (In Russian)
33. Andrushchuk V.V., Polonetski O.L., Ostrovski Yu.P., Kurganovich S.A., Gevorkyan T.T., Kurushko T.V., Krushevskaja T.V. Coronary arteries stenting in patients with tumors of major locations and concomitant coronary heart disease. Cardiology in Belarus. 2020; 12:483–94. doi:10.34883/PI.2020.12.4.004. (In Russian)
34. Alekyan B.G., Ruchkin D.V., Karapetyan N.G., Irodova N.L., Meleshenko N.N., Geletsyan L.G., Revishvili A.Sh. Case report of a multidisciplinary approach to one-time treatment of a patient with critical aortic valve stenosis, lesion of the left main coronary artery and bleeding stomach cancer. Patologiya krovoobrashcheniya i kardiokhirurgiya = Circulation Pathology and Cardiac Surgery. 2022; 26:58-65. doi: 10.21688/1681-3472-2022-2-58-65. (In Russian)
35. Baquet M., Jochheim D., Mehilli J. Polymer-free drug-eluting stents for coronary artery disease. Journal of Interventional Cardiology 2018;31:330–7. doi:10.1111/joic.12499.
36. Urban P., Meredith I.T., Abizaid A., Pocock S.J., Carrié D., Naber C., et al. Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk. New England Journal of Medicine 2015;373. doi:10.1056/nejmoa1503943.
Supplementary files
Review
For citations:
Alekyan B.G., Karapetyan N.G., Gritskevich A.A., Gyoletsyan L.G., Galstyan A.V., Revishvili A.Sh. CARDIAC ONCOLOGY: A MODERN VIEW ON THE PROBLEM OF CHOOSING AN OPTIMAL STRATEGY FOR THE TREATMENT OF CORONARY ARTERY DISEASE AND CANCER. Complex Issues of Cardiovascular Diseases. 2023;12(3):98-108. (In Russ.) https://doi.org/10.17802/2306-1278-2023-12-3-98-108
Views:
504
